These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8396395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.
    Zecca L, Shima T, Stroppolo A, Goj C, Battiston GA, Gerbasi R, Sarna T, Swartz HM.
    Neuroscience; 1996 Jul; 73(2):407-15. PubMed ID: 8783258
    [Abstract] [Full Text] [Related]

  • 3. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.
    Enochs WS, Nilges MJ, Swartz HM.
    J Neurochem; 1993 Jul; 61(1):68-79. PubMed ID: 8390568
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain.
    Zecca L, Pietra R, Goj C, Mecacci C, Radice D, Sabbioni E.
    J Neurochem; 1994 Mar; 62(3):1097-101. PubMed ID: 8113797
    [Abstract] [Full Text] [Related]

  • 7. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
    Biesemeier A, Eibl O, Eswara S, Audinot JN, Wirtz T, Pezzoli G, Zucca FA, Zecca L, Schraermeyer U.
    J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
    [Abstract] [Full Text] [Related]

  • 8. Neuromelanin of the human substantia nigra: an update.
    Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L, Zecca L.
    Neurotox Res; 2014 Jan; 25(1):13-23. PubMed ID: 24155156
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems.
    Zareba M, Bober A, Korytowski W, Zecca L, Sarna T.
    Biochim Biophys Acta; 1995 Jun 09; 1271(2-3):343-8. PubMed ID: 7605801
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T.
    Lee H, Baek SY, Chun SY, Lee JH, Cho H.
    Neuroimage; 2018 May 15; 172():874-885. PubMed ID: 29162523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A.
    Neuroreport; 2006 Jul 31; 17(11):1215-8. PubMed ID: 16837857
    [Abstract] [Full Text] [Related]

  • 15. Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.
    Aime S, Bergamasco B, Casu M, Digilio G, Fasano M, Giraudo S, Lopiano L.
    Mov Disord; 2000 Sep 31; 15(5):977-81. PubMed ID: 11009208
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
    Reimão S, Ferreira S, Nunes RG, Pita Lobo P, Neutel D, Abreu D, Gonçalves N, Campos J, Ferreira JJ.
    Eur J Neurol; 2016 Feb 31; 23(2):368-74. PubMed ID: 26518135
    [Abstract] [Full Text] [Related]

  • 19. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP.
    Mov Disord; 2011 Aug 01; 26(9):1633-8. PubMed ID: 21491489
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.